Phase II of oral gimatecan in patients with recurrent epithelial ovarian, fallopian tube or peritoneal cancer, previously treated with platinum and taxanes-Reference-Cited by-同舟云学术

Phase II of oral gimatecan in patients with recurrent epithelial ovarian, fallopian tube or peritoneal cancer, previously treated with platinum and taxanes

Published:2010-04 Issue:4 Volume:21 Page:759-765
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Pecorelli S.,Ray-Coquard I.,Tredan O.,Colombo N.,Parma G.,Tisi G.,Katsaròs D.,Lhommé C.,Lissoni A.A.,Vermorken J.B.,du Bois A.,Poveda A.,Frigerio L.,Barbieri P.,Carminati P.,Brienza S.,Guastalla J.P.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/21/4/759/366989/mdp514.pdf

Reference16 articles.

1. Duration of response to second-line, platinum-based chemotherapy for ovarian cancer: implications for patient management and clinical trial design;Markman;J Clin Oncol,2004

2. Recurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin versus topotecan;Gordon;J Clin Oncol,2001

3. Topotecan versus paclitaxel for the treatment of recurrent epithelial ovarian cancer;Bokkel Huinink;J Clin Oncol,1997

4. Gemcitabine plus carboplatin compared with carboplatin in patients with platinum-sensitive recurrent ovarian cancer: an intergroup trial of the AGO-OVAR, the NCI CTG, and the EORTC GCG;Pfisterer;J Clin Oncol,2006

5. Trabectedin for women with ovarian carcinoma after treatment with platinum and taxanes fails;Sessa;J Clin Oncol,2005

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Semisynthetic phytochemicals in cancer treatment: a medicinal chemistry perspective;RSC Medicinal Chemistry;2024

2. DNA intercalation and topoisomerase inhibition;Medicinal Chemistry of Anticancer Drugs;2023

3. Natural Products/Bioactive Compounds as a Source of Anticancer Drugs;Cancers;2022-12-15

4. Identification of Compounds That Inhibit Estrogen-Related Receptor Alpha Signaling Using High-Throughput Screening Assays;Molecules;2019-02-27

5. High Efficacy of Intravenous Gimatecan on Human Tumor Xenografts;Anticancer Research;2018-10